Sabby Management’s IVERIC bio, Inc. Common Stock ISEE Stock Holding History

Sabby Management’s Portfolio ISEE Stock Details ISEE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-1,438	Closed	-$173K	–	138
2018 Q4	$173K	Buy	1,438 +221	+18%	+$428	0.04%	74
2018 Q3	$287K	Hold	1,217	–	–	0.04%	88
2018 Q2	$332K	Buy	+1,217	New	+$3.36K	0.05%	92
2017 Q1	–	Sell	-883	Closed	-$426K	–	334
2016 Q4	$426K	Sell	883 -634	-42%	-$18.8K	0.02%	207
2016 Q3	$7M	Buy	1,517 +1,156	+320%	+$65.2K	0.26%	60
2016 Q2	$1.84M	Buy	+361	New	+$17.9K	0.1%	116
2015 Q4	–	Sell	-140	Closed	-$567K	–	384
2015 Q3	$567K	Buy	+140	New	+$7.42K	0.02%	282

Other funds holding ISEE

SCM

Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return

Tamarack Advisers Carlsbad, California $2.12M AUM 58.09% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $43.4B AUM 51.29% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

Sabby Management's ISEE Position: Q1 2019 in Review

Sabby Management sold out of IVERIC bio, Inc. Common Stock (ISEE) in Q1 2019, closing a stake of 2,037,460 shares — an estimated $2.44M sold.

Sabby Management first reported a position in ISEE in Q1 2014 and held it in 4 quarters. The position peaked at $3.82M in Q3 2018. 58 funds tracked by Wall St. Rank hold ISEE as of Q1 2019.

Sabby Management reported no remaining IVERIC bio, Inc. Common Stock position as of Q1 2019 after selling out during the quarter.
Sabby Management sold 2,037,460 IVERIC bio, Inc. Common Stock shares in Q1 2019, an estimated $2.44M.
Sabby Management first reported a position in IVERIC bio, Inc. Common Stock in Q1 2014 and held it in 4 quarters.
Sabby Management's IVERIC bio, Inc. Common Stock position peaked at $3.82M in Q3 2018.
58 funds tracked by Wall St. Rank held IVERIC bio, Inc. Common Stock as of Q1 2019.

Based on Sabby Management's 13F filing for Q1 2019, filed 15 May 2019.